AAAAAA

   
Results: 1-14 |
Results: 14
Single-dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using I-131-labeled multivalent CC49 single-chain Fvs(1)
Authors: Goel, A Augustine, S Baranowska-Kortylewicz, J Colcher, D Booth, BJM Pavlinkova, G Tempero, M Batra, SK
Citation: A. Goel et al., Single-dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using I-131-labeled multivalent CC49 single-chain Fvs(1), CLIN CANC R, 7(1), 2001, pp. 175-184
Tc-99m-labeled divalent and tetravalent CC49 single-chain Fv's: Novel imaging agents for rapid in vivo localization of human colon carcinoma
Authors: Goel, A Baranowska-Kortylewicz, J Hinrichs, SH Wisecarver, J Pavlinkova, G Augustine, S Colcher, D Booth, BJM Batra, SK
Citation: A. Goel et al., Tc-99m-labeled divalent and tetravalent CC49 single-chain Fv's: Novel imaging agents for rapid in vivo localization of human colon carcinoma, J NUCL MED, 42(10), 2001, pp. 1519-1527
Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-TAG-72 single-chain Fvs
Authors: Pavlinkova, G Colcher, D Booth, BJM Goel, A Wittel, UA Batra, SK
Citation: G. Pavlinkova et al., Effects of humanization and gene shuffling on immunogenicity and antigen binding of anti-TAG-72 single-chain Fvs, INT J CANC, 94(5), 2001, pp. 717-726
Site-specific photobiotinylation of antibodies, light chains, and immunoglobulin fragments
Authors: Pavlinkova, G Lou, DY Kohler, H
Citation: G. Pavlinkova et al., Site-specific photobiotinylation of antibodies, light chains, and immunoglobulin fragments, METHODS, 22(1), 2000, pp. 44-48
Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct
Authors: Pavlinkova, G Colcher, D Booth, BJM Goel, A Batra, SK
Citation: G. Pavlinkova et al., Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct, CANCER IMMU, 49(4-5), 2000, pp. 267-275
Relative position of the hexahistidine tag effects binding properties of atumor-associated single-chain Fv construct
Authors: Goel, A Colcher, D Koo, JS Booth, BJM Pavlinkova, G Batra, SK
Citation: A. Goel et al., Relative position of the hexahistidine tag effects binding properties of atumor-associated single-chain Fv construct, BBA-GEN SUB, 1523(1), 2000, pp. 13-20
Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: Expression, purification, and characterization
Authors: Goel, A Beresford, GW Colcher, D Pavlinkova, G Booth, BJM Baranowska-Kortylewicz, J Batra, SK
Citation: A. Goel et al., Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: Expression, purification, and characterization, J BIOCHEM, 127(5), 2000, pp. 829-836
Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: Improved biodistribution and potential for therapeutic application
Authors: Goel, A Colcher, D Baranowska-Kortylewicz, J Augustine, S Booth, BJM Pavlinkova, G Batra, SK
Citation: A. Goel et al., Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: Improved biodistribution and potential for therapeutic application, CANCER RES, 60(24), 2000, pp. 6964-6971
Effects of genetic engineering on the pharmacokinetics of antibodies
Authors: Colcher, D Goel, A Pavlinkova, G Beresford, G Booth, B Batra, SK
Citation: D. Colcher et al., Effects of genetic engineering on the pharmacokinetics of antibodies, Q J NUCL M, 43(2), 1999, pp. 132-139
Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct
Authors: Pavlinkova, G Booth, BJM Batra, SK Colcher, D
Citation: G. Pavlinkova et al., Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct, CLIN CANC R, 5(9), 1999, pp. 2613-2619
Charge-modified single chain antibody constructs of monoclonal antibody CC49: Generation, characterization, pharmacokinetics, and biodistribution analysis
Authors: Pavlinkova, G Beresford, G Booth, BJM Batra, SK Colcher, D
Citation: G. Pavlinkova et al., Charge-modified single chain antibody constructs of monoclonal antibody CC49: Generation, characterization, pharmacokinetics, and biodistribution analysis, NUCL MED BI, 26(1), 1999, pp. 27-34
Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts
Authors: Pavlinkova, G Beresford, GW Booth, BJM Batra, SK Colcher, D
Citation: G. Pavlinkova et al., Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts, J NUCL MED, 40(9), 1999, pp. 1536-1546
Binding characteristics and tumor targeting of a covalently linked divalent CC49 single-chain antibody
Authors: Beresford, GW Pavlinkova, G Booth, BJM Batra, SK Colcher, D
Citation: Gw. Beresford et al., Binding characteristics and tumor targeting of a covalently linked divalent CC49 single-chain antibody, INT J CANC, 81(6), 1999, pp. 911-917
Pharmacokinetics and biodistribution of genetically-engineered antibodies
Authors: Colcher, D Pavlinkova, G Beresford, G Booth, BJM Choudhury, A Batra, SK
Citation: D. Colcher et al., Pharmacokinetics and biodistribution of genetically-engineered antibodies, Q J NUCL M, 42(4), 1998, pp. 225-241
Risultati: 1-14 |